Loading…

Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation

The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2019-10, Vol.120, p.10-19
Main Authors: Yuan, Ping, Huang, Sha, Bao, Fei-Chao, Cao, Jin-Lin, Sheng, Hong-Xu, Shi, Liang, Lv, Wang, Hu, Jian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23
cites cdi_FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23
container_end_page 19
container_issue
container_start_page 10
container_title European journal of cancer (1990)
container_volume 120
creator Yuan, Ping
Huang, Sha
Bao, Fei-Chao
Cao, Jin-Lin
Sheng, Hong-Xu
Shi, Liang
Lv, Wang
Hu, Jian
description The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation. The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients’ clinical outcomes with a median follow-up of 57 months (2–99 months). The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p 
doi_str_mv 10.1016/j.ejca.2019.06.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2280557153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804919304162</els_id><sourcerecordid>2308478513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhiMEokvhBTggS1y4ZBk7cdYrcUEtFKRKXOBsOfak9SqOg-206kvyTEy6bQ8cuHhG9vePZ-avqrccthx49_GwxYM1WwF8v4VuC6J9Vm242u1rUFI8rzawl_taQbs_qV7lfACAnWrhZXXS8LbtBBeb6s-5zzb54CdT_HTFTM7ResrjxOLADLMxBMoLjjFgMhlZwhtMFEsy06qdy3o7pxhiwcTmON6FmOZrnwO79eX6UUuMSSYgQZn5iU1xqnMw48gs0jEu9L01k6Ua97J4jHEpDGfvMBHLrlK8pbfB2ELvCS3OaxKWct_z6-rFYMaMbx7iafXr65efZ9_qyx8X388-X9a2UW2pzdApcAoMul663lqwjegtgpCuA1ANF6ppuVRKugGF4VK4rutlw_tdI51oTqsPx7o09u8Fc9GB9khjmAnjkrUQCqTccdkQ-v4f9BCXNFF3WjSg2p2SfKXEkbIp5pxw0DO5YtKd5qBXt_VBr27r1W0NnSa3SfTuofTSB3RPkkd7Cfh0BJB2ceMx6Ww90oqdp9UV7aL_X_2_9HjB3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2308478513</pqid></control><display><type>article</type><title>Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation</title><source>Elsevier</source><creator>Yuan, Ping ; Huang, Sha ; Bao, Fei-Chao ; Cao, Jin-Lin ; Sheng, Hong-Xu ; Shi, Liang ; Lv, Wang ; Hu, Jian</creator><creatorcontrib>Yuan, Ping ; Huang, Sha ; Bao, Fei-Chao ; Cao, Jin-Lin ; Sheng, Hong-Xu ; Shi, Liang ; Lv, Wang ; Hu, Jian</creatorcontrib><description>The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation. The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients’ clinical outcomes with a median follow-up of 57 months (2–99 months). The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p &lt; 0.001 for both) and shorter RTL (versus C/C and versus T/T; p = 0.039 and 0.023) in patients without EGFR mutation. Such difference was not observed in their counterparts harbouring EGFR mutation. When considering the cohort as a whole, T/C allele was significantly associated with shortest overall survival compared with T/T or C/C allele (mean: 61.8, 80.9 and 88.7 months, plog-rank &lt; 0.001) and disease-free survival (mean: 78.3, 87.9 and 91.5 months, plog-rank = 0.019). Stratification analyses showed that the negative prognostic effect of T/C on OS was constrained in patients without EGFR mutation. Our study revealed significant associations of a common SNP within TERT promoter region on telomere parameters and survival in NSCLC patients without EGFR mutation. The result may help providing instruction for therapeutic interventions targeting telomerase and evidence for investigation of TERT-EGFR interacting mechanism in telomere biology. •T/C allele is significantly associated with telomere parameters in patients without epidermal growth factor receptor (EGFR) mutation.•T/C allele is significantly associated with shorter overall survival in patients without EGFR mutation.•Investigation of telomerase reverse transcriptase-EGFR interacting mechanism in telomere biology need to be focussed in future research.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2019.06.024</identifier><identifier>PMID: 31446212</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alleles ; Epidermal growth factor ; Epidermal growth factor receptor mutation (EGFR) ; Epidermal growth factor receptors ; Gene expression ; Gene polymorphism ; Growth factors ; Impact analysis ; Lung cancer ; Mutation ; Non-small cell lung cancer (NSCLC) ; Non-small cell lung carcinoma ; Nucleotides ; Parameters ; Polymorphism ; RNA-directed DNA polymerase ; rs2853669 single-nucleotide polymorphism (rs2853669 SNP) ; Single-nucleotide polymorphism ; Small cell lung carcinoma ; Survival ; Survival outcome ; Telomerase ; Telomerase reverse transcriptase ; Telomerase reverse transcriptase (TERT) ; Telomere length ; Therapeutic applications ; Tumors</subject><ispartof>European journal of cancer (1990), 2019-10, Vol.120, p.10-19</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Oct 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23</citedby><cites>FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31446212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Ping</creatorcontrib><creatorcontrib>Huang, Sha</creatorcontrib><creatorcontrib>Bao, Fei-Chao</creatorcontrib><creatorcontrib>Cao, Jin-Lin</creatorcontrib><creatorcontrib>Sheng, Hong-Xu</creatorcontrib><creatorcontrib>Shi, Liang</creatorcontrib><creatorcontrib>Lv, Wang</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><title>Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation. The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients’ clinical outcomes with a median follow-up of 57 months (2–99 months). The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p &lt; 0.001 for both) and shorter RTL (versus C/C and versus T/T; p = 0.039 and 0.023) in patients without EGFR mutation. Such difference was not observed in their counterparts harbouring EGFR mutation. When considering the cohort as a whole, T/C allele was significantly associated with shortest overall survival compared with T/T or C/C allele (mean: 61.8, 80.9 and 88.7 months, plog-rank &lt; 0.001) and disease-free survival (mean: 78.3, 87.9 and 91.5 months, plog-rank = 0.019). Stratification analyses showed that the negative prognostic effect of T/C on OS was constrained in patients without EGFR mutation. Our study revealed significant associations of a common SNP within TERT promoter region on telomere parameters and survival in NSCLC patients without EGFR mutation. The result may help providing instruction for therapeutic interventions targeting telomerase and evidence for investigation of TERT-EGFR interacting mechanism in telomere biology. •T/C allele is significantly associated with telomere parameters in patients without epidermal growth factor receptor (EGFR) mutation.•T/C allele is significantly associated with shorter overall survival in patients without EGFR mutation.•Investigation of telomerase reverse transcriptase-EGFR interacting mechanism in telomere biology need to be focussed in future research.</description><subject>Alleles</subject><subject>Epidermal growth factor</subject><subject>Epidermal growth factor receptor mutation (EGFR)</subject><subject>Epidermal growth factor receptors</subject><subject>Gene expression</subject><subject>Gene polymorphism</subject><subject>Growth factors</subject><subject>Impact analysis</subject><subject>Lung cancer</subject><subject>Mutation</subject><subject>Non-small cell lung cancer (NSCLC)</subject><subject>Non-small cell lung carcinoma</subject><subject>Nucleotides</subject><subject>Parameters</subject><subject>Polymorphism</subject><subject>RNA-directed DNA polymerase</subject><subject>rs2853669 single-nucleotide polymorphism (rs2853669 SNP)</subject><subject>Single-nucleotide polymorphism</subject><subject>Small cell lung carcinoma</subject><subject>Survival</subject><subject>Survival outcome</subject><subject>Telomerase</subject><subject>Telomerase reverse transcriptase</subject><subject>Telomerase reverse transcriptase (TERT)</subject><subject>Telomere length</subject><subject>Therapeutic applications</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhiMEokvhBTggS1y4ZBk7cdYrcUEtFKRKXOBsOfak9SqOg-206kvyTEy6bQ8cuHhG9vePZ-avqrccthx49_GwxYM1WwF8v4VuC6J9Vm242u1rUFI8rzawl_taQbs_qV7lfACAnWrhZXXS8LbtBBeb6s-5zzb54CdT_HTFTM7ResrjxOLADLMxBMoLjjFgMhlZwhtMFEsy06qdy3o7pxhiwcTmON6FmOZrnwO79eX6UUuMSSYgQZn5iU1xqnMw48gs0jEu9L01k6Ua97J4jHEpDGfvMBHLrlK8pbfB2ELvCS3OaxKWct_z6-rFYMaMbx7iafXr65efZ9_qyx8X388-X9a2UW2pzdApcAoMul663lqwjegtgpCuA1ANF6ppuVRKugGF4VK4rutlw_tdI51oTqsPx7o09u8Fc9GB9khjmAnjkrUQCqTccdkQ-v4f9BCXNFF3WjSg2p2SfKXEkbIp5pxw0DO5YtKd5qBXt_VBr27r1W0NnSa3SfTuofTSB3RPkkd7Cfh0BJB2ceMx6Ww90oqdp9UV7aL_X_2_9HjB3g</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Yuan, Ping</creator><creator>Huang, Sha</creator><creator>Bao, Fei-Chao</creator><creator>Cao, Jin-Lin</creator><creator>Sheng, Hong-Xu</creator><creator>Shi, Liang</creator><creator>Lv, Wang</creator><creator>Hu, Jian</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation</title><author>Yuan, Ping ; Huang, Sha ; Bao, Fei-Chao ; Cao, Jin-Lin ; Sheng, Hong-Xu ; Shi, Liang ; Lv, Wang ; Hu, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alleles</topic><topic>Epidermal growth factor</topic><topic>Epidermal growth factor receptor mutation (EGFR)</topic><topic>Epidermal growth factor receptors</topic><topic>Gene expression</topic><topic>Gene polymorphism</topic><topic>Growth factors</topic><topic>Impact analysis</topic><topic>Lung cancer</topic><topic>Mutation</topic><topic>Non-small cell lung cancer (NSCLC)</topic><topic>Non-small cell lung carcinoma</topic><topic>Nucleotides</topic><topic>Parameters</topic><topic>Polymorphism</topic><topic>RNA-directed DNA polymerase</topic><topic>rs2853669 single-nucleotide polymorphism (rs2853669 SNP)</topic><topic>Single-nucleotide polymorphism</topic><topic>Small cell lung carcinoma</topic><topic>Survival</topic><topic>Survival outcome</topic><topic>Telomerase</topic><topic>Telomerase reverse transcriptase</topic><topic>Telomerase reverse transcriptase (TERT)</topic><topic>Telomere length</topic><topic>Therapeutic applications</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Ping</creatorcontrib><creatorcontrib>Huang, Sha</creatorcontrib><creatorcontrib>Bao, Fei-Chao</creatorcontrib><creatorcontrib>Cao, Jin-Lin</creatorcontrib><creatorcontrib>Sheng, Hong-Xu</creatorcontrib><creatorcontrib>Shi, Liang</creatorcontrib><creatorcontrib>Lv, Wang</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Ping</au><au>Huang, Sha</au><au>Bao, Fei-Chao</au><au>Cao, Jin-Lin</au><au>Sheng, Hong-Xu</au><au>Shi, Liang</au><au>Lv, Wang</au><au>Hu, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2019-10</date><risdate>2019</risdate><volume>120</volume><spage>10</spage><epage>19</epage><pages>10-19</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation. The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients’ clinical outcomes with a median follow-up of 57 months (2–99 months). The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p &lt; 0.001 for both) and shorter RTL (versus C/C and versus T/T; p = 0.039 and 0.023) in patients without EGFR mutation. Such difference was not observed in their counterparts harbouring EGFR mutation. When considering the cohort as a whole, T/C allele was significantly associated with shortest overall survival compared with T/T or C/C allele (mean: 61.8, 80.9 and 88.7 months, plog-rank &lt; 0.001) and disease-free survival (mean: 78.3, 87.9 and 91.5 months, plog-rank = 0.019). Stratification analyses showed that the negative prognostic effect of T/C on OS was constrained in patients without EGFR mutation. Our study revealed significant associations of a common SNP within TERT promoter region on telomere parameters and survival in NSCLC patients without EGFR mutation. The result may help providing instruction for therapeutic interventions targeting telomerase and evidence for investigation of TERT-EGFR interacting mechanism in telomere biology. •T/C allele is significantly associated with telomere parameters in patients without epidermal growth factor receptor (EGFR) mutation.•T/C allele is significantly associated with shorter overall survival in patients without EGFR mutation.•Investigation of telomerase reverse transcriptase-EGFR interacting mechanism in telomere biology need to be focussed in future research.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31446212</pmid><doi>10.1016/j.ejca.2019.06.024</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8049
ispartof European journal of cancer (1990), 2019-10, Vol.120, p.10-19
issn 0959-8049
1879-0852
language eng
recordid cdi_proquest_miscellaneous_2280557153
source Elsevier
subjects Alleles
Epidermal growth factor
Epidermal growth factor receptor mutation (EGFR)
Epidermal growth factor receptors
Gene expression
Gene polymorphism
Growth factors
Impact analysis
Lung cancer
Mutation
Non-small cell lung cancer (NSCLC)
Non-small cell lung carcinoma
Nucleotides
Parameters
Polymorphism
RNA-directed DNA polymerase
rs2853669 single-nucleotide polymorphism (rs2853669 SNP)
Single-nucleotide polymorphism
Small cell lung carcinoma
Survival
Survival outcome
Telomerase
Telomerase reverse transcriptase
Telomerase reverse transcriptase (TERT)
Telomere length
Therapeutic applications
Tumors
title Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A12%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discriminating%20association%20of%20a%20common%20telomerase%20reverse%20transcriptase%20promoter%20polymorphism%20with%20telomere%20parameters%20in%20non-small%20cell%20lung%20cancer%20with%20or%20without%20epidermal%20growth%20factor%20receptor%20mutation&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Yuan,%20Ping&rft.date=2019-10&rft.volume=120&rft.spage=10&rft.epage=19&rft.pages=10-19&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2019.06.024&rft_dat=%3Cproquest_cross%3E2308478513%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-af680d80aedb5dbcc0c32bce025d600831283415885dfe2a152d66b531b735d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2308478513&rft_id=info:pmid/31446212&rfr_iscdi=true